MedPath

Treatment of hay fever in relation to asthma, in children.

Recruiting
Conditions
Allergic Rhinitis (allergische rinitis)Asthma (astma)
Registration Number
NL-OMON26975
Lead Sponsor
Erasmuc MC, Rotterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
477
Inclusion Criteria

1. Children aged 6-18 years;

2. Recruitment in general practice based on doctor’s diagnosis AR (ICPC R97) or prescription of allergy medication (antihistamines, INCS) in the past;

Exclusion Criteria

1. Use of INCS one month prior to randomization or antihistamines one week prior to randomization;

2. Currently pregnant or breastfeeding;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of (nose and eye) symptom free days during 3 months in the tree/grass pollen season.
Secondary Outcome Measures
NameTimeMethod
1. Allergy symptom score;<br /><br>2. (Rescue)medication free days;<br /><br>3. AR-specific quality of life;<br /><br>4. Patient’s preference of medication.<br /><br>Outcomes regarding the effectiveness of AR-treatment on asthma: % days without asthma symptoms, asthma symptom score, asthma medication free days, asthma quality of life, and degree of asthma control.
© Copyright 2025. All Rights Reserved by MedPath